{"id":448,"date":"2019-12-30T18:07:36","date_gmt":"2019-12-30T23:07:36","guid":{"rendered":"http:\/\/ayslcorp.com\/blog\/?p=448"},"modified":"2019-12-30T18:07:36","modified_gmt":"2019-12-30T23:07:36","slug":"the-costs-of-drugs-dont-seem-to-gibe-with-reality","status":"publish","type":"post","link":"https:\/\/ayslcorp.com\/blog\/index.php\/2019\/12\/30\/the-costs-of-drugs-dont-seem-to-gibe-with-reality\/","title":{"rendered":"The costs of drugs don’t seem to gibe with reality."},"content":{"rendered":"\n

\n\nOr is it just me who has a problem dealing with big numbers? As an example, let’s take the new drug, Ingrezza (valbenazine), for treating a manmade disease caused by taking common medications used in mental illnesses and their associated side effects. The new disease is Tardive Dyskinesia. It costs each patient $200 to $400 a day or $73,000 to $146,000 a year! There are half a million TD sufferers in the United States. If only half of them (250,000) were treated with this drug, it would afford its manufacturer up to $3.65 billion. This amount is not much lower than the $10.7 billion of Eli Lilly & Company\u2019s sales in the first half year of 2019 for all of its drugs, as reported in C&EN, August 12, 2019, p. 13. Still, its annual sales would be only about $22 billion. While Ingrezza by itself gets 1\/6 equivalent of Eli Lilly’s annual sales. Where is the rest hidden? Would someone economically intelligent explain to us plain scientists why drug sales are reported at only $billions but rarely, if ever, in $trillions, where they seem most likely to belong?\nhashtag#drug<\/a>hashtag#costs<\/a>hashtag#manmade<\/a>hashtag#newdisease<\/a>hashtag#Ingrezza<\/a>hashtag#mentalillnesses<\/a>hashtag#drugcaused<\/a>hashtag#valbenazine<\/a>hashtag#Elililly<\/a>hashtag#tardivedyskinesia<\/a> $trillionsvsbillions\n\n<\/p>\n","protected":false},"excerpt":{"rendered":"

Or is it just me who has a problem dealing with big numbers? As an example, let’s take the new drug, Ingrezza (valbenazine), for treating a manmade disease caused by taking common medications used in mental illnesses and their associated side effects. The new disease is Tardive Dyskinesia. It costs each patient $200 to $400 … <\/p>\n

Continue reading “The costs of drugs don’t seem to gibe with reality.”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-448","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/posts\/448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/comments?post=448"}],"version-history":[{"count":0,"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/posts\/448\/revisions"}],"wp:attachment":[{"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/media?parent=448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/categories?post=448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ayslcorp.com\/blog\/index.php\/wp-json\/wp\/v2\/tags?post=448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}